Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Journal of Translational Medicine
Published in: Journal of Translational Medicine 1/2020

Open Access 01-12-2020 | Atorvastatin | Review

The effects of statins on dental and oral health: a review of preclinical and clinical studies

Authors: Shabnam Tahamtan, Farinaz Shirban, Mohammad Bagherniya, Thomas P. Johnston, Amirhossein Sahebkar

Published in: Journal of Translational Medicine | Issue 1/2020

Login to get access

Abstract

The statin family of drugs are safe and effective therapeutic agents for the treatment of arteriosclerotic cardiovascular disease (CVD). Due to a wide range of health benefits in addition to their cholesterol lowering properties, statins have recently attracted significant attention as a new treatment strategy for several conditions, which are not directly related to normalizing a lipid profile and preventing CVD. Statins exert a variety of beneficial effects on different aspects of oral health, which includes their positive effects on bone metabolism, their anti-inflammatory and antioxidant properties, and their potential effects on epithelization and wound healing. Additionally, they possess antimicrobial, antiviral, and fungicidal properties, which makes this class of drugs attractive to the field of periodontal diseases and oral and dental health. However, to the best of our knowledge, there has been no comprehensive study to date, which has investigated the effects of statin drugs on different aspects of dental and oral health. Therefore, the primary objective of this paper was to review the effect of statins on dental and oral health. Results of our extensive review have indicated that statins possess remarkable and promising effects on several aspects of dental and oral health including chronic periodontitis, alveolar bone loss due to either extraction or chronic periodontitis, osseointegration of implants, dental pulp cells, orthodontic tooth movement, and orthodontic relapse, tissue healing (wound/bone healing), salivary gland function, and finally, anti-cancer effects. Hence, statins can be considered as novel, safe, inexpensive, and widely-accessible therapeutic agents to improve different aspects of dental and oral health.
Literature
1.
Petersen PE. The World oral health report 2003: continuous improvement of oral health in the 21st century–the approach of the WHO Global Oral Health Programme. Community Dent Oral Epidemiol. 2003;31(Suppl 1):3–23.PubMedCrossRef
2.
Petersen PE, Bourgeois D, Bratthall D, Ogawa H. Oral health information systems–towards measuring progress in oral health promotion and disease prevention. Bull World Health Organ. 2005;83:686–93.PubMedPubMedCentral
3.
Petersen PE, Bourgeois D, Ogawa H, Estupinan-Day S, Ndiaye C. The global burden of oral diseases and risks to oral health. Bull World Health Organ. 2005;83:661–9.PubMedPubMedCentral
4.
Righolt AJ, Jevdjevic M, Marcenes W, Listl S. Global-, regional-, and country-level economic impacts of dental diseases in 2015. J Dent Res. 2018;97:501–7.PubMedCrossRef
5.
Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci. 2017;11:72–80.
6.
Bergstrom J. Smoking rate and periodontal disease prevalence: 40-year trends in Sweden 1970–2010. J Clin Periodontol. 2014;41:952–7.PubMedCrossRef
7.
Casanova L, Hughes FJ, Preshaw PM. Diabetes and periodontal disease: a two-way relationship. Br Dent J. 2014;217:433–7.PubMedCrossRef
8.
Rai B, Kaur J, Anand SC, Jacobs R. Salivary stress markers, stress, and periodontitis: a pilot study. J Periodontol. 2011;82:287–92.PubMedCrossRef
9.
10.
Ide M, Papapanou PN. Epidemiology of association between maternal periodontal disease and adverse pregnancy outcomes–systematic review. J Periodontol. 2013;84:S181–94.PubMedCrossRef
11.
Martinez-Herrera M, Silvestre-Rangil J, Silvestre FJ. Association between obesity and periodontal disease. A systematic review of epidemiological studies and controlled clinical trials. Med Oral Patol Oral Cir Bucal. 2017;22:708–15.
12.
13.
Teshome A, Yitayeh A. The effect of periodontal therapy on glycemic control and fasting plasma glucose level in type 2 diabetic patients: systematic review and meta-analysis. BMC Oral Health. 2016;17:31.PubMedPubMedCentralCrossRef
14.
Ridker PM, Cook NR. Statins: new American guidelines for prevention of cardiovascular disease. Lancet. 2013;382:1762–5.PubMedCrossRef
15.
Lefer AM, Scalia R, Lefer DJ. Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease. Cardiovasc Res. 2001;49:281–7.PubMedCrossRef
16.
17.
Rauch U, Osende J, Chesebro J, Fuster V, Vorchheimer D, Harris K, Harris P, Sandler D, Fallon J, Jayaraman S. Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins. Atherosclerosis. 2000;153:181–9.PubMedCrossRef
18.
Taylor F, Ward K, Moore TH, Burke M, Smith GD, Casas JP, Ebrahim S. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2011;15(1):17–29.
19.
Shitara Y, Sugiyama Y. Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug–drug interactions and interindividual differences in transporter and metabolic enzyme functions. Pharmacol Ther. 2006;112:71–105.PubMedCrossRef
20.
21.
Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med. 2009;360:1851–61.PubMedPubMedCentralCrossRef
22.
Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov. 2005;4:977–87.PubMedCrossRef
23.
Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Statins: pros and cons. Med Clin (Barc). 2018;150:398–402.CrossRef
24.
Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G. Stimulation of bone formation in vitro and in rodents by statins. Science. 1999;286:1946–9.PubMedCrossRef
25.
Chruściel P, Sahebkar A, Rembek-Wieliczko M, Serban MC, Ursoniu S, Mikhailidis DP, Jones SR, Mosteoru S, Blaha MJ, Martin SS, et al. Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms. Atherosclerosis. 2016;253:194–208.PubMedCrossRef
26.
Parizadeh SMR, Azarpazhooh MR, Moohebati M, Nematy M, Ghayour-Mobarhan M, Tavallaie S, Rahsepar AA, Amini M, Sahebkar A, Mohammadi M, Ferns GAA. Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial. Lipids. 2011;46:333–40.PubMedCrossRef
27.
Sahebkar A, Kotani K, Serban C, Ursoniu S, Mikhailidis DP, Jones SR, Ray KK, Blaha MJ, Rysz J, Toth PP, et al. Statin therapy reduces plasma endothelin-1 concentrations: a meta-analysis of 15 randomized controlled trials. Atherosclerosis. 2015;241:433–42.PubMedCrossRef
28.
Sahebkar A, Serban C, Mikhailidis DP, Undas A, Lip GYH, Muntner P, Bittner V, Ray KK, Watts GF, Hovingh GK, et al. Association between statin use and plasma d-dimer levels: a systematic review and meta-analysis of randomised controlled trials. Thromb Haemost. 2015;114:546–57.PubMedCrossRef
29.
Sahebkar A, Serban C, Ursoniu S, Mikhailidis DP, Undas A, Lip GYH, Bittner V, Ray KK, Watts GF, Kees Hovingh G, et al. The impact of statin therapy on plasma levels of von Willebrand factor antigen: systematic review and meta-analysis of Randomised placebo-controlled trials. Thromb Haemost. 2016;115:520–32.PubMedCrossRef
30.
31.
Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Effects of statins on bone mineral density: a meta-analysis of clinical studies. Bone. 2007;40:1581–7.PubMedCrossRef
32.
Bertl K, Parllaku A, Pandis N, Buhlin K, Klinge B, Stavropoulos A. The effect of local and systemic statin use as an adjunct to non-surgical and surgical periodontal therapy-A systematic review and meta-analysis. J Dent. 2017;67:18–28.PubMedCrossRef
33.
Zhang Y, Bradley AD, Wang D, Reinhardt RA. Statins, bone metabolism and treatment of bone catabolic diseases. Pharmacol Res. 2014;88:53–61.PubMedCrossRef
34.
Jia W, Zhao Y, Yang J, Wang W, Wang X, Ling L, Ge L. Simvastatin promotes dental pulp stem cell-induced coronal pulp regeneration in pulpotomized teeth. J Endod. 2016;42:1049–54.PubMedCrossRef
35.
Lin HP, Tu HP, Hsieh YP, Lee BS. Controlled release of lovastatin from poly(lactic-co-glycolic acid) nanoparticles for direct pulp capping in rat teeth. Int J Nanomed. 2017;12:5473–85.CrossRef
36.
Pettiette MT, Zhong S, Moretti AJ, Khan AA. Potential correlation between statins and pulp chamber calcification. J Endod. 2013;39:1119–23.PubMedCrossRef
37.
38.
Ma L, Niknejad N, Gorn-Hondermann I, Dayekh K, Dimitroulakos J. Lovastatin induces multiple stress pathways including LKB1/AMPK activation that regulate its cytotoxic effects in squamous cell carcinoma cells. PLoS ONE. 2012;7:e46055.PubMedPubMedCentralCrossRef
39.
Bitto A, Minutoli L, Altavilla D, Polito F, Fiumara T, Marini H, Galeano M, Calo M, Lo Cascio P, Bonaiuto M, et al. Simvastatin enhances VEGF production and ameliorates impaired wound healing in experimental diabetes. Pharmacol Res. 2008;57:159–69.PubMedCrossRef
40.
Rego AC, Araujo Filho I, Damasceno BP, Egito ES, Silveira IA, Brandao-Neto J, Medeiros AC. Simvastatin improves the healing of infected skin wounds of rats. Acta Cir Bras. 2007;22(Suppl 1):57–63.PubMedCrossRef
41.
Emani S, Gunjiganur GV, Mehta DS. Determination of the antibacterial activity of simvastatin against periodontal pathogens, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans: an in vitro study. Contemp Clin Dent. 2014;5:377–82.PubMedPubMedCentralCrossRef
42.
Masadeh M, Mhaidat N, Alzoubi K, Al-Azzam S, Alnasser Z. Antibacterial activity of statins: a comparative study of atorvastatin, simvastatin, and rosuvastatin. Ann Clin Microbiol Antimicrob. 2012;11:13.PubMedPubMedCentralCrossRef
43.
Akram Z, Vohra F, Javed F. Efficacy of statin delivery as an adjunct to scaling and root planing in the treatment of chronic periodontitis: a meta-analysis. J Investig Clin Dent. 2018;9:e12304.PubMedCrossRef
44.
Bertl K, Steiner I, Pandis N, Buhlin K, Klinge B, Stavropoulos A. Statins in nonsurgical and surgical periodontal therapy. A systematic review and meta-analysis of preclinical in vivo trials. J Periodontal Res. 2018;53:267–87.PubMedCrossRef
45.
46.
Maritz FJ, Conradie MM, Hulley PA, Gopal R, Hough S. Effect of statins on bone mineral density and bone histomorphometry in rodents. Arterioscler Thromb Vasc Biol. 2001;21:1636–41.PubMedCrossRef
47.
Kellesarian SV, Al Amri MD, Al-Kheraif AA, Ghanem A, Malmstrom H, Javed F. Efficacy of local and systemic statin delivery on the osseointegration of implants: a systematic review. Int J Oral Maxillofac Implants. 2017;32:497–506.PubMedCrossRef
48.
Estanislau IM, Terceiro IR, Lisboa MR, Teles Pde B, Carvalho Rde S, Martins RS, Moreira MM. Pleiotropic effects of statins on the treatment of chronic periodontitis–a systematic review. Br J Clin Pharmacol. 2015;79:877–85.PubMedPubMedCentralCrossRef
49.
Meza-Mauricio J, Soto-Penaloza D, Penarrocha-Oltra D, Montiel-Company JM, Peruzzo DC. Locally applied statins as adjuvants to non-surgical periodontal treatment for chronic periodontitis: a systematic review and meta-analysis. Clin Oral Investig. 2018;22:2413–30.PubMedCrossRef
50.
Muniz F, Taminski K, Cavagni J, Celeste RK, Weidlich P, Rosing CK. The effect of statins on periodontal treatment-a systematic review with meta-analyses and meta-regression. Clin Oral Investig. 2018;22:671–87.PubMedCrossRef
51.
Ting M, Whitaker EJ, Albandar JM. Systematic review of the in vitro effects of statins on oral and perioral microorganisms. Eur J Oral Sci. 2016;124:4–10.PubMedCrossRef
52.
Arnaud C, Burger F, Steffens S, Veillard NR, Nguyen TH, Trono D, Mach F. Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins. Arterioscler Thromb Vasc Biol. 2005;25:1231–6.PubMedCrossRef
53.
Lin SK, Kok SH, Lee YL, Hou KL, Lin YT, Chen MH, Wang CC, Hong CY. Simvastatin as a novel strategy to alleviate periapical lesions. J Endod. 2009;35:657–62.PubMedCrossRef
54.
Paumelle R, Blanquart C, Briand O, Barbier O, Duhem C, Woerly G, Percevault F, Fruchart JC, Dombrowicz D, Glineur C, Staels B. Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway. Circ Res. 2006;98:361–9.PubMedCrossRef
55.
Sakoda K, Yamamoto M, Negishi Y, Liao JK, Node K, Izumi Y. Simvastatin decreases IL-6 and IL-8 production in epithelial cells. J Dent Res. 2006;85:520–3.PubMedCrossRef
56.
Liu S, Bertl K, Sun H, Liu ZH, Andrukhov O, Rausch-Fan X. Effect of simvastatin on the osteogenetic behavior of alveolar osteoblasts and periodontal ligament cells. Hum Cell. 2012;25:29–35.PubMedCrossRef
57.
Maeda T, Kawane T, Horiuchi N. Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation. Endocrinology. 2003;144:681–92.PubMedCrossRef
58.
Viereck V, Grundker C, Blaschke S, Frosch KH, Schoppet M, Emons G, Hofbauer LC. Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts. J Cell Biochem. 2005;96:1244–53.PubMedCrossRef
59.
Davignon J, Laaksonen R. Low-density lipoprotein-independent effects of statins. Curr Opin Lipidol. 1999;10:543–59.PubMedCrossRef
60.
Luan Z, Chase AJ, Newby AC. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol. 2003;23:769–75.PubMedCrossRef
61.
Poston CJ, Pierce TC, Li Y, Brinson CW, Lu Z, Lauer AW, Leite RS, Huang Y. Statin intake is associated with MMP-1 level in gingival crevicular fluid of patients with periodontitis. Oral Dis. 2016;22:438–44.PubMedPubMedCentralCrossRef
62.
Park A, Barrera-Ramirez J, Ranasinghe I, Pilon S, Sy R, Fergusson D, Allan DS. Use of statins to augment progenitor cell function in preclinical and clinical studies of regenerative therapy: a systematic review. Stem Cell Rev Rep. 2016;12:327–39.PubMedCrossRef
63.
Shah SR, Werlang CA, Kasper FK, Mikos AG. Novel applications of statins for bone regeneration. Natl Sci Rev. 2015;2:85–99.PubMedCrossRef
64.
Song C, Guo Z, Ma Q, Chen Z, Liu Z, Jia H, Dang G. Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells. Biochem Biophys Res Commun. 2003;308:458–62.PubMedCrossRef
65.
Staal A, Frith JC, French MH, Swartz J, Gungor T, Harrity TW, Tamasi J, Rogers MJ, Feyen JH. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity. J Bone Miner Res. 2003;18:88–96.PubMedCrossRef
66.
Noronha Oliveira M, Rau LH, Marodin A, Correa M, Correa LR, Aragones A, Magini RS. Ridge preservation after maxillary third molar extraction using 30% porosity PLGA/HA/beta-TCP scaffolds with and without simvastatin: a pilot randomized controlled clinical trial. Implant Dent. 2017;26:832–40.PubMedCrossRef
67.
Rakhmatia YD, Ayukawa Y, Furuhashi A, Koyano K. Carbonate apatite containing statin enhances bone formation in healing incisal extraction sockets in rats. Materials (Basel). 2018;11(7):1201.CrossRef
68.
Sezavar M, Bohlouli B, Farhadi S, Tabatabaee S, Latifi R. Simvastatin effects on dental socket quality: a comparative study. Contemp Clin Dent. 2018;9:55–9.PubMedPubMedCentral
69.
Liu C, Wu Z, Sun HC. The effect of simvastatin on mRNA expression of transforming growth factor-beta1, bone morphogenetic protein-2 and vascular endothelial growth factor in tooth extraction socket. Int J Oral Sci. 2009;1:90–8.PubMedPubMedCentralCrossRef
70.
Wu Z, Liu C, Zang G, Sun H. The effect of simvastatin on remodelling of the alveolar bone following tooth extraction. Int J Oral Maxillofac Surg. 2008;37:170–6.PubMedCrossRef
71.
de Mones E, Schlaubitz S, Catros S, Fricain JC. Statins and alveolar bone resorption: a narrative review of preclinical and clinical studies. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119:65–73.PubMedCrossRef
72.
Goes P, Lima AP, Melo IM, Rego RO, Lima V. Effect of Atorvastatin in radiographic density on alveolar bone loss in wistar rats. Braz Dent J. 2010;21:193–8.PubMedCrossRef
73.
Goes P, Lima NA, Rodrigues JA, Benevides NM, Brito GA, Lima V. Anti-inflammatory and Anti-resorptive effects of Atorvastatin on alveolar bone loss in Wistar Rats. Braz Dent J. 2016;27:267–72.PubMedCrossRef
74.
Goes P, Melo IM, Silva LM, Benevides NM, Alencar NM, Ribeiro RA, Lima V. Low-dose combination of alendronate and atorvastatin reduces ligature-induced alveolar bone loss in rats. J Periodontal Res. 2014;49:45–54.PubMedCrossRef
75.
Nassar PO, Nassar CA, Guimaraes MR, Aquino SG, Andia DC, Muscara MN, Spolidorio DM, Rossa C Jr, Spolidorio LC. Simvastatin therapy in cyclosporine A-induced alveolar bone loss in rats. J Periodontal Res. 2009;44:479–88.PubMedCrossRef
76.
Pokhrel NK, Kim YG, Kim JY, Kim HH, Lee Y. Fluvastatin inhibits osteoclast differentiation and Porphyromonas gingivalis Lipopolysaccharide-Induced alveolar bone erosion in mice. J Periodontol. 2017;88:390–8.PubMedCrossRef
77.
Seto H, Ohba H, Tokunaga K, Hama H, Horibe M, Nagata T. Topical administration of simvastatin recovers alveolar bone loss in rats. J Periodontal Res. 2008;43:261–7.PubMedCrossRef
78.
Tanigo T, Takaoka R, Tabata Y. Sustained release of water-insoluble simvastatin from biodegradable hydrogel augments bone regeneration. J Control Release. 2010;143:201–6.PubMedCrossRef
79.
Tan WL, Wong TL, Wong MC, Lang NP. A systematic review of post-extractional alveolar hard and soft tissue dimensional changes in humans. Clin Oral Implants Res. 2012;23(Suppl 5):1–21.PubMedCrossRef
80.
Price U, Le HO, Powell SE, Schmid MJ, Marx DB, Zhang Y, Wang D, Narayana N, Reinhardt RA. Effects of local simvastatin-alendronate conjugate in preventing periodontitis bone loss. J Periodontal Res. 2013;48:541–8.PubMedCrossRef
81.
Dalcico R, de Menezes AM, Deocleciano OB, Oria RB, Vale ML, Ribeiro RA, Brito GA. Protective mechanisms of simvastatin in experimental periodontal disease. J Periodontol. 2013;84:1145–57.PubMedCrossRef
82.
Fajardo ME, Rocha ML, Sanchez-Marin FJ, Espinosa-Chavez EJ. Effect of atorvastatin on chronic periodontitis: a randomized pilot study. J Clin Periodontol. 2010;37:1016–22.PubMedCrossRef
83.
Jin J, Machado ER, Yu H, Zhang X, Lu Z, Li Y, Lopes-Virella MF, Kirkwood KL, Huang Y. Simvastatin inhibits LPS-induced alveolar bone loss during metabolic syndrome. J Dent Res. 2014;93:294–9.PubMedPubMedCentralCrossRef
84.
Jin J, Zhang X, Lu Z, Li Y, Lopes-Virella MF, Yu H, Haycraft CJ, Li Q, Kirkwood KL, Huang Y. Simvastatin inhibits lipopolysaccharide-induced osteoclastogenesis and reduces alveolar bone loss in experimental periodontal disease. J Periodontal Res. 2014;49:518–26.PubMedCrossRef
85.
Machado WM, Prestes AP, Costa TP, Mendes RT, Olchanheski LR Jr, Sordi R, Otuki MF, Favero GM, Vellosa JC, Santos FA, Fernandes D. The effect of simvastatin on systemic inflammation and endothelial dysfunction induced by periodontitis. J Periodontal Res. 2014;49:634–41.PubMedCrossRef
86.
Nassar CA, Battistetti GD, Nahsan FP, Olegario J, Marconato J, Marin CF, Faccioni DM, da Costa KF, Kottwitz LB, Nassar PO. Evaluation of the effect of simvastatin on the progression of alveolar bone loss in experimental periodontitis–an animal study. J Int Acad Periodontol. 2014;16:2–7.PubMed
87.
Sundararaj SC, Thomas MV, Peyyala R, Dziubla TD, Puleo DA. Design of a multiple drug delivery system directed at periodontitis. Biomaterials. 2013;34:8835–42.PubMedPubMedCentralCrossRef
88.
Pradeep AR, Priyanka N, Kalra N, Naik SB, Singh SP, Martande S. Clinical efficacy of subgingivally delivered 1.2-mg simvastatin in the treatment of individuals with class II furcation defects: a randomized controlled clinical trial. J Periodontol. 2012;83:1472–9.PubMedCrossRef
89.
Pradeep AR, Rao NS, Bajaj P, Kumari M. Efficacy of subgingivally delivered simvastatin in the treatment of patients with type 2 diabetes and chronic periodontitis: a randomized double-masked controlled clinical trial. J Periodontol. 2013;84:24–31.PubMedCrossRef
90.
Pradeep AR, Thorat MS. Clinical effect of subgingivally delivered simvastatin in the treatment of patients with chronic periodontitis: a randomized clinical trial. J Periodontol. 2010;81:214–22.PubMedCrossRef
91.
Fu JH, Bashutski JD, Al-Hezaimi K, Wang HL. Statins, glucocorticoids, and nonsteroidal anti-inflammatory drugs: their influence on implant healing. Implant Dent. 2012;21:362–7.PubMedCrossRef
92.
Moraschini V, Almeida DCF, Calasans-Maia JA, Diuana Calasans-Maia M. The ability of topical and systemic statins to increase osteogenesis around dental implants: a systematic review of histomorphometric outcomes in animal studies. Int J Oral Maxillofac Surg. 2018;47:1070–8.PubMedCrossRef
93.
Moriyama Y, Ayukawa Y, Ogino Y, Atsuta I, Koyano K. Topical application of statin affects bone healing around implants. Clin Oral Implants Res. 2008;19:600–5.PubMedCrossRef
94.
Moriyama Y, Ayukawa Y, Ogino Y, Atsuta I, Todo M, Takao Y, Koyano K. Local application of fluvastatin improves peri-implant bone quantity and mechanical properties: a rodent study. Acta Biomater. 2010;6:1610–8.PubMedCrossRef
95.
Ayukawa Y, Okamura A, Koyano K. Simvastatin promotes osteogenesis around titanium implants. Clin Oral Implants Res. 2004;15:346–50.PubMedCrossRef
96.
Ayukawa Y, Ogino Y, Moriyama Y, Atsuta I, Jinno Y, Kihara M, Tsukiyama Y, Koyano K. Simvastatin enhances bone formation around titanium implants in rat tibiae. J Oral Rehabil. 2010;37:123–30.PubMedCrossRef
97.
Basarir K, Erdemli B, Can A, Erdemli E, Zeyrek T. Osseointegration in arthroplasty: can simvastatin promote bone response to implants? Int Orthop. 2009;33:855–9.PubMedCrossRef
98.
Du Z, Chen J, Yan F, Xiao Y. Effects of Simvastatin on bone healing around titanium implants in osteoporotic rats. Clin Oral Implants Res. 2009;20:145–50.PubMedCrossRef
99.
Tan J, Yang N, Fu X, Cui Y, Guo Q, Ma T, Yin X, Leng H, Song C. Single-dose local simvastatin injection improves implant fixation via increased angiogenesis and bone formation in an ovariectomized rat model. Med Sci Monit. 2015;21:1428–39.PubMedPubMedCentralCrossRef
100.
Masuzaki T, Ayukawa Y, Moriyama Y, Jinno Y, Atsuta I, Ogino Y, Koyano K. The effect of a single remote injection of statin-impregnated poly (lactic-co-glycolic acid) microspheres on osteogenesis around titanium implants in rat tibia. Biomaterials. 2010;31:3327–34.PubMedCrossRef
101.
Fang W, Zhao S, He F, Liu L, Yang G. Influence of simvastatin-loaded implants on osseointegration in an ovariectomized animal model. Biomed Res Int. 2015;2015:831504.PubMedPubMedCentral
102.
Giro G, Chambrone L, Goldstein A, Rodrigues JA, Zenobio E, Feres M, Figueiredo LC, Cassoni A, Shibli JA. Impact of osteoporosis in dental implants: a systematic review. World J Orthop. 2015;6:311–5.PubMedPubMedCentralCrossRef
103.
Huang W, Shang WL, Li DH, Wu WW, Hou SX. Simvastatin protects osteoblast against H2O2-induced oxidative damage via inhibiting the upregulation of Nox4. Mol Cell Biochem. 2012;360:71–7.PubMedCrossRef
104.
Alghofaily M, Tordik P, Romberg E, Martinho F, Fouad AF. Healing of apical periodontitis after nonsurgical root canal treatment: the role of statin intake. J Endod. 2018;44:1355–60.PubMedCrossRef
105.
Asl Aminabadi N, Maljaei E, Erfanparast L, Ala Aghbali A, Hamishehkar H, Najafpour E. Simvastatin versus calcium hydroxide direct pulp capping of human primary molars: a randomized clinical trial. J Dent Res Dent Clin Dent Prospects. 2013;7:8–14.PubMedPubMedCentral
106.
Varalakshmi PR, Kavitha M, Govindan R, Narasimhan S. Effect of statins with alpha-tricalcium phosphate on proliferation, differentiation, and mineralization of human dental pulp cells. J Endod. 2013;39:806–12.PubMedCrossRef
107.
AlSwafeeri H, ElKenany W, Mowafy M, Karam S. Effect of local administration of simvastatin on postorthodontic relapse in a rabbit model. Am J Orthod Dentofacial Orthop. 2018;153:861–71.PubMedCrossRef
108.
Dolci GS, Ballarini A, Gameiro GH, de Souza DO, de Melo F, Fossati AC. Atorvastatin inhibits osteoclastogenesis and arrests tooth movement. Am J Orthod Dentofacial Orthop. 2018;153:872–82.PubMedCrossRef
109.
Dolci GS, Portela LV, de Souza DO, de Medeiros Fossati AC. Atorvastatin-induced osteoclast inhibition reduces orthodontic relapse. Am J Orthod Dentofacial Orthop. 2017;151:528–38.PubMedCrossRef
110.
Han G, Chen Y, Hou J, Liu C, Chen C, Zhuang J, Meng W. Effects of simvastatin on relapse and remodeling of periodontal tissues after tooth movement in rats. Am J Orthod Dentofacial Orthop. 2010;138:550.e551.
111.
Jahanbin A, Abtahi M, Namdar P, Heravi F, Sadeghi F, Arab H, Shafaee H. Evaluation of the effects of subgingival injection of Simvastatin on space re-opening after orthodontic space closure in adults. J Dent Res Dent Clin Dent Prospects. 2016;10:3–7.PubMedPubMedCentralCrossRef
112.
MirHashemi AH, Afshari M, Alaeddini M, Etemad-Moghadam S, Dehpour A, Sheikhzade S, Akhoundi MS. Effect of atorvastatin on orthodontic tooth movement in male wistar rats. J Dent. 2013;10:532–9.
113.
Vieira GM, Chaves SB, Ferreira VM, Freitas KM, Amorim RF. The effect of simvastatin on relapse of tooth movement and bone mineral density in rats measured by a new method using microtomography. Acta Cir Bras. 2015;30:319–27.PubMedCrossRef
114.
AlSwafeeri H, ElKenany W, Mowafy M, Karam S. Effect of local administration of simvastatin on postorthodontic relapse in a rabbit model. Am J Orthod Dentofac Orthop. 2018;153:861–71.CrossRef
115.
Grasser WA, Baumann AP, Petras SF, Harwood HJ Jr, Devalaraja R, Renkiewicz R, Baragi V, Thompson DD, Paraklar VM. Regulation of osteoclast differentiation by statins. J Musculoskelet Neuronal Interact. 2003;3:53–62.PubMed
116.
Madi M, Kassem A. Topical simvastatin gel as a novel therapeutic modality for palatal donor site wound healing following free gingival graft procedure. Acta Odontol Scand. 2018;76:212–9.PubMedCrossRef
117.
Rutledge J, Schieber MD, Chamberlain JM, Byarlay M, Killeen AC, Giannini PJ, Marx DB, Reinhardt RA. Simvastatin application to augment facial jaw bone in a dog model: pilot study. J Periodontol. 2011;82:597–605.PubMedCrossRef
118.
Turer A, Durmuslar MC, Sener I, Misir AF, Onger ME. The effect of local rosuvastatin on Mandibular fracture healing. J Craniofac Surg. 2016;27:e758–61.PubMedCrossRef
119.
Asai J, Takenaka H, Hirakawa S, Sakabe J, Hagura A, Kishimoto S, Maruyama K, Kajiya K, Kinoshita S, Tokura Y, Katoh N. Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis. Am J Pathol. 2012;181:2217–24.PubMedCrossRef
120.
Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, Sessa WC, Walsh K. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med. 2000;6:1004–10.PubMedPubMedCentralCrossRef
121.
122.
Xu L, Yang X, Chen J, Ge X, Qin Q, Zhu H, Zhang C, Sun X. Simvastatin attenuates radiation-induced salivary gland dysfunction in mice. Drug Des Devel Ther. 2016;10:2271–8.PubMedPubMedCentralCrossRef
123.
Cai WY, Zhuang Y, Yan F, Li T, Song WT, Sun JH. Effect of survivin downregulation by simvastatin on the growth and invasion of salivary adenoid cystic carcinoma. Mol Med Rep. 2018;18:1939–46.PubMedPubMedCentral
124.
Pavan LM, Rego DF, Elias ST, De Luca Canto G, Guerra EN. In vitro Anti-Tumor effects of statins on head and neck squamous cell Carcinoma: a systematic review. PLoS ONE. 2015;10:e0130476.PubMedPubMedCentralCrossRef
125.
Wang C, Li T, Yan F, Cai W, Zheng J, Jiang X, Sun J. Effect of simvastatin and microRNA-21 inhibitor on metastasis and progression of human salivary adenoid cystic carcinoma. Biomed Pharmacother. 2018;105:1054–61.PubMedCrossRef
126.
Belcher R, Hayes K, Fedewa S, Chen AY. Current treatment of head and neck squamous cell cancer. J Surg Oncol. 2014;110:551–74.PubMedCrossRef
127.
Gabrys D, Dorfler A, Yaromina A, Hessel F, Krause M, Oertel R, Baumann M. Effects of lovastatin alone or combined with irradiation on tumor cells in vitro and in vivo. Strahlenther Onkol. 2008;184:48–53.PubMedCrossRef
128.
Mantha AJ, McFee KE, Niknejad N, Goss G, Lorimer IA, Dimitroulakos J. Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells. J Cancer Res Clin Oncol. 2003;129:631–41.PubMedCrossRef
129.
Mantha AJ, Hanson JE, Goss G, Lagarde AE, Lorimer IA, Dimitroulakos J. Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor. Clin Cancer Res. 2005;11:2398–407.PubMedCrossRef
130.
Dayekh K, Johnson-Obaseki S, Corsten M, Villeneuve PJ, Sekhon HS, Weberpals JI, Dimitroulakos J. Monensin inhibits epidermal growth factor receptor trafficking and activation: synergistic cytotoxicity in combination with EGFR inhibitors. Mol Cancer Ther. 2014;13:2559–71.PubMedCrossRef
131.
de Llobet LI, Baro M, Mesia R, Balart J. Simvastatin enhances the effects of radiotherapy and cetuximab on a cell line (FaDu) derived from a Ssquamous cell carcinoma of head and neck. Transl Oncol. 2014;7:513–22.PubMedPubMedCentralCrossRef
132.
Niknejad N, Gorn-Hondermann I, Ma L, Zahr S, Johnson-Obeseki S, Corsten M, Dimitroulakos J. Lovastatin-induced apoptosis is mediated by activating transcription factor 3 and enhanced in combination with salubrinal. Int J Cancer. 2014;134:268–79.PubMedCrossRef
133.
Dimitroulakos J, Marhin WH, Tokunaga J, Irish J, Gullane P, Penn LZ, Kamel-Reid S. Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas. Neoplasia. 2002;4:337–46.PubMedPubMedCentralCrossRef
134.
Takeda I, Maruya S, Shirasaki T, Mizukami H, Takahata T, Myers JN, Kakehata S, Yagihashi S, Shinkawa H. Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells. Cancer Sci. 2007;98:890–9.PubMedCrossRef
135.
Assaggaf MA, Kantarci A, Sume SS, Trackman PC. Prevention of phenytoin-induced gingival overgrowth by lovastatin in mice. Am J Pathol. 2015;185:1588–99.PubMedPubMedCentralCrossRef
136.
Medeiros CA, Leitao RF, Macedo RN, Barboza DR, Gomes AS, Nogueira NA, Alencar NM, Ribeiro RA, Brito GA. Effect of atorvastatin on 5-fluorouracil-induced experimental oral mucositis. Cancer Chemother Pharmacol. 2011;67:1085–100.PubMedCrossRef
137.
Hong HH, Uzel MI, Duan C, Sheff MC, Trackman PC. Regulation of lysyl oxidase, collagen, and connective tissue growth factor by TGF-beta1 and detection in human gingiva. Lab Invest. 1999;79:1655–67.PubMed
138.
Uzel MI, Kantarci A, Hong HH, Uygur C, Sheff MC, Firatli E, Trackman PC. Connective tissue growth factor in drug-induced gingival overgrowth. J Periodontol. 2001;72:921–31.PubMedCrossRef
139.
Pascual Cruz M, Chimenos Kustner E, Garcia Vicente JA, Mezquiriz Ferrero X, Borrell Thio E, Lopez Lopez J. Adverse side effects of statins in the oral cavity. Med Oral Patol Oral Cir Bucal. 2008;13:E98–101.PubMed
Metadata
Title
The effects of statins on dental and oral health: a review of preclinical and clinical studies
Authors
Shabnam Tahamtan
Farinaz Shirban
Mohammad Bagherniya
Thomas P. Johnston
Amirhossein Sahebkar
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2020
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-020-02326-8

Other articles of this Issue 1/2020

Journal of Translational Medicine 1/2020 Go to the issue

Research

Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1

Research

Phosphatidylcholine PC ae C44:6 in cerebrospinal fluid is a sensitive biomarker for bacterial meningitis

Research

LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation

Review

Angiocrine endothelium: from physiology to cancer

Research

The establishment of a rheumatoid arthritis primate model in Macaca fascicularis

Research

A machine learning-based clinical tool for diagnosing myopathy using multi-cohort microarray expression profiles
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits